Oxazoles
Cambridge Isotope Laboratories Dimethyl phthalate (ring-D4 98%) 100 /- 10 ug/mL in nonane 1 2 mL
Dimethyl phthalate (ring-D4 98%) 100 /- 10 ug/mL in nonane 1 2 mL
![Medchemexpress LLC tert-Butyl (1S,4S,5R)-5-hydroxy-2-azabicyclo[2.2.1]heptane-2-carboxylate | 1932042-59-5 | 97.8% | 213.28 | 500 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000404310-logo.png-250.jpg){kind=logo}
Medchemexpress LLC tert-Butyl (1S,4S,5R)-5-hydroxy-2-azabicyclo[2.2.1]heptane-2-carboxylate | 1932042-59-5 | 97.8% | 213.28 | 500 MG
tert-Butyl (1S,4S,5R)-5-hydroxy-2-azabicyclo[2.2.1]heptane-2-carboxylate is a drug intermediate for the synthesis of various active compounds. It is for research use only.
- Available in multiple sizes
- White to off-white solid appearance
- Molecular weight of 213.28
- Detailed documentation available
- Stable under recommended storage conditions
Aobchem 4-(5 5-Dimethyl-1 3 2-dioxaborinan-2-yl)-3-methyl-benzonitrile | ≥97% | CAS 2231089-47-5 | C13H16BNO2 | 500mg
4-(5 5-Dimethyl-1 3 2-dioxaborinan-2-yl)-3-methyl-benzonitrile | ≥97% | CAS 2231089-47-5 | C13H16BNO2 | 500mg
Aobchem Methyl 2-(2 4-difluorophenoxy)acetate | ≥95% | CAS 449811-63-6 | C9H8F2O3 | 1g
Methyl 2-(2 4-difluorophenoxy)acetate | ≥95% | CAS 449811-63-6 | C9H8F2O3 | 1g
Aobchem 2 2-Dimethyl-3-decyn-5-one | 95% | CAS 89319-66-4 | C12H20O | 5g
2 2-Dimethyl-3-decyn-5-one | 95% | CAS 89319-66-4 | C12H20O | 5g
Aobchem 3-[(2 4-Difluorophenoxy)methyl]benzonitrile | 97% | CAS 1019128-43-8 | C14H9F2NO | 250mg
3-[(2 4-Difluorophenoxy)methyl]benzonitrile | 97% | CAS 1019128-43-8 | C14H9F2NO | 250mg
Aobchem 3-[(2 4-Difluorophenoxy)methyl]benzonitrile | 97% | CAS 1019128-43-8 | C14H9F2NO | 1g
3-[(2 4-Difluorophenoxy)methyl]benzonitrile | 97% | CAS 1019128-43-8 | C14H9F2NO | 1g
Aobchem 3-[(2 4-Difluorophenoxy)methyl]benzonitrile | 97% | CAS 1019128-43-8 | C14H9F2NO | 500mg
3-[(2 4-Difluorophenoxy)methyl]benzonitrile | 97% | CAS 1019128-43-8 | C14H9F2NO | 500mg
![Medchemexpress LLC 5-Amino-1,3-dimethyl-6-(3-propoxyphenoxy)-1H-benzo[d]imidazol-2(3H)-one | 1800477-35-3 | 96.9% | 327.38 | 250 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000402937-logo.png-250.jpg){kind=logo}
Medchemexpress LLC 5-Amino-1,3-dimethyl-6-(3-propoxyphenoxy)-1H-benzo[d]imidazol-2(3H)-one | 1800477-35-3 | 96.9% | 327.38 | 250 MG
This chemical is 5-Amino-1,3-dimethyl-6-(3-propoxyphenoxy)-1H-benzo[d]imidazol-2(3H)-one, identified for use as a laboratory chemical and in the manufacture of substances.
- Used as a laboratory chemical.
- Used in the manufacture of substances.
- Off-white to light yellow solid.
- Recommended storage conditions for powder and in solvent.
- For research use only.
Medchemexpress LLC (2S,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid | 1012341-52-4 | 99.0% | C23H29NO4 | 50 MG
(2S,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid is a drug intermediate for the synthesis of various active compounds. It is intended for research use only and not for sale to patients.
- Drug intermediate for synthesis of various active compounds
- For research use only
- Appears as a solid
- Storage as powder: -20°C for 3 years, 4°C for 2 years
- Storage in solvent: -80°C for 6 months, -20°C for 1 month
eMolecules 811-93-8 | 1,1-DIMETHYL-1,2-ETHANEDIAMINE | AstaTech | MFCD00008054 | 88.154 | C4H12N2 | 95.000 | CC(C)(N)CN | 25g | 553400325
1,1-DIMETHYL-1,2-ETHANEDIAMINE | AstaTech | 811-93-8 | MFCD00008054 | 88.154 | C4H12N2 | 95.000 | CC(C)(N)CN | 25g | 553400325
Medchemexpress LLC (4S)-GLP-1 receptor agonist 14 | 2758659-09-3 | 99.6% | 880.94 | 25 MG
(4S)-GLP-1 receptor agonist 14 is a potent and orally active GLP-1 receptor agonist with an EC50 ≤ 20 nM. It can be used for research on diabetes, obesity, metabolic diseases, cardiovascular diseases, liver diseases, nonalcoholic steatohepatitis (NASH), and other diseases associated with the GLP-1 receptor.
- Potent and orally active GLP-1 receptor agonist
- EC50 ≤ 20 nM
- Applicable for research on various diseases including diabetes, obesity, metabolic diseases, cardiovascular diseases, liver diseases, and nonalcoholic steatohepatitis (NASH)